IMproved PREdiction of Severe Sepsis in the Emergency Department

Completed

Conditions studied: Systemic Inflammatory Response Syndrome (SIRS), Sepsis, Severe Sepsis, Septic Shock

In brief

The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department with suspected infection.

Key facts

Study ID

NCT01392508

Run by

Axis Shield Diagnostics Ltd

People needed

759

Starts

2011-03-01

Expected to finish

2015-09-01

Last updated by the study team

2017-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Greater than or equal to 18 years
• Suspected Infection
• one or more SIRS criteria

Where it is running

• Cooper University Hospital — Camden, New Jersey, United States
• Universitetssjukhuset i Linkoping — Linköping, Sweden
• Skanes Universitetssjukhus i Lund — Lund, Sweden
• Skanes Universitetssjukhuset i Malmo — Malmö, Sweden
• Universitetssjukhuset i Orebro — Örebro, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.